NCT03244891

Brief Summary

Heart Rate Variability (HRV) analysis has been studied in the critically ill patients although it is affected by several uncontrolled variables in the clinical conditions. The aim of this trial is to measure the effects of mildly reduced central volume and cyclic variation of intrathoracic pressure on the variables frequently used to describe the HRV.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 10, 2017

Completed
1.8 years until next milestone

Study Start

First participant enrolled

June 15, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2019

Completed
Last Updated

October 14, 2019

Status Verified

October 1, 2019

Enrollment Period

2 months

First QC Date

August 5, 2017

Last Update Submit

October 10, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Effects of increasing central blood volume on heart rate variability

    The studied subjects will undergo to increase of central blood volume in two steps: 1. passive head down tilt at -7 degrees 2. intravenous infusion of ringer acetate of 15ml\*kg body weight

    10 mins each step

  • Effect of cyclic intrathoracic pressure oscillations on heart rate variability

    The studied subject will undergo to two ventilatory modes: 1. spontaneous breathing at 18 breaths per min 2. positive pressure ventilation via face mask

    10 min each step

Secondary Outcomes (1)

  • Effects of increasing central blood volume and of cyclic intrathoracic pressure oscillations on echographic cardiac function variables

    10 mins each step

Study Arms (1)

Studied subjects

EXPERIMENTAL

Each subject will be studied during two sequential phases: 1. before fluid challenge 2. after fluid challenge During each phase, the subjects will be studied at: 1. baseline - spontaneously breathing 2. head down position - spontaneously breathing 3. baseline - positive pressure ventilation 4. head down position - positive pressure ventilation The sequence a-b-c-d will be randomized for each subject and for each phase

Other: Increase of central volumeOther: Ventilation mode

Interventions

Mild hypovolemia will be induced in healthy volunteers by 12 hours fasting. Three conditions will be considered for the analysis, each of them both during spontaneous breathing and positive pressure ventilation: 1. baseline 2. after fluid shift induced by passive head down position at 15 degrees 3. after fluid challenge with Ringer acetate 15ml\*kg in head down position A total of six steps will be considered for the analysis

Studied subjects

Each previous step will be done in two respiratory conditions: 1. spontaneous breathing 2. noninvasive ventilation via facial mask in pressure support mode at 8 cmH2O above positive end expiratory pressure of 5 cmH2O, inspiratory fraction of oxygen of 0.25 In both conditions respiratory rate will be set at 18 breaths per min following a metronome

Studied subjects

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy volunteers

You may not qualify if:

  • history of cardiac, metabolic, respiratory, renal, neurological or hematologic disease of any kind
  • chronically assuming drugs of any kind
  • non sinus cardiac rhythm
  • ectopic beats \>5% of all cardiac beats
  • claustrophobia or unable to tolerate noninvasive ventilation via facial mask

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ASST Fatebenefratelli Sacco, Luigi Sacco Hospital

Milan, 20157, Italy

Location

Related Publications (6)

  • Guyton JE, Arthur C. The Autonomic Nervous System and The Adrenal Medulla, in Textbook of Medical Physiology, 12th ed., Saunders Elsevier, Ed. Philadelphia, 2011, pp. 738-739

    BACKGROUND
  • Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981 Jul 10;213(4504):220-2. doi: 10.1126/science.6166045.

    PMID: 6166045BACKGROUND
  • Ferrario M, Moissl U, Garzotto F, Cruz DN, Tetta C, Signorini MG, Ronco C, Grassmann A, Cerutti S, Guzzetti S. The forgotten role of central volume in low frequency oscillations of heart rate variability. PLoS One. 2015 Mar 20;10(3):e0120167. doi: 10.1371/journal.pone.0120167. eCollection 2015.

    PMID: 25793464BACKGROUND
  • Galletly DC, Larsen PD. Relationship between cardioventilatory coupling and respiratory sinus arrhythmia. Br J Anaesth. 1998 Feb;80(2):164-8. doi: 10.1093/bja/80.2.164.

    PMID: 9602579BACKGROUND
  • Monnet X, Rienzo M, Osman D, Anguel N, Richard C, Pinsky MR, Teboul JL. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med. 2006 May;34(5):1402-7. doi: 10.1097/01.CCM.0000215453.11735.06.

    PMID: 16540963BACKGROUND
  • Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.

    PMID: 8598068BACKGROUND

MeSH Terms

Conditions

Hypovolemia

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Design

Study Type
interventional
Phase
not applicable
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 5, 2017

First Posted

August 10, 2017

Study Start

June 15, 2019

Primary Completion

July 30, 2019

Study Completion

July 30, 2019

Last Updated

October 14, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations